Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing Expectations of Surgical End-Users Through Prospective Surveying During a Period of Electronic Health Record Transition.

Studies in health technology and informatics·2026
Same author

Evolutionary role of physician leaders in healthcare informatics and health technology.

Health informatics journal·2025
Same author

Insights and Trends in Open Note Access: Retrospective Observational Study.

Journal of medical Internet research·2024
Same author

Triumph over adversity: Unlocking optimal trauma outcomes during healthcare ransomware attacks.

Injury·2023
Same author

Effect of dialysate bicarbonate and sodium on blood pH in maintenance hemodialysis-A prospective study.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·2022
Same author

Defining Data Migration Across Multidisciplinary Ambulatory Clinics Using Participatory Design.

Applied clinical informatics·2021
Same journal

Metabolic Syndrome and Risk of Atrial Fibrillation in Chronic Kidney Disease.

American journal of nephrology·2026
Same journal

Premature Aortic Stiffness in Relation to Cerebral Small Vessel Disease, Cognitive Decline, Major Cardiovascular Events and Mortality in Dialysis.

American journal of nephrology·2026
Same journal

Adjudicating heart failure as an end point in dialysis trials- more signal, less noise.

American journal of nephrology·2026
Same journal

Bridging the Evidence-to-Practice Gap in Hypertension: Why Innovation Isn't Always Implementation.

American journal of nephrology·2026
Same journal

Adjudicating Heart Failure Events in Participants Receiving Hemodialysis: Findings from Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

American journal of nephrology·2026
Same journal

Beyond the Amount: The Selectivity of Proteinuria and Risk of Graft Failure in Kidney Transplant Recipients.

American journal of nephrology·2026
See all related articles

Related Experiment Video

Updated: Jul 3, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Nephrogenic systemic fibrosis.

Neha Nainani1, Mandip Panesar

  • 1State University of New York at Buffalo, Buffalo, NY, USA.

American Journal of Nephrology
|July 30, 2008
PubMed
Summary
This summary is machine-generated.

Nephrogenic systemic fibrosis (NSF) is a serious condition linked to gadolinium exposure in patients with kidney problems. Research is ongoing to understand its causes and find effective treatments.

Related Experiment Videos

Last Updated: Jul 3, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Area of Science:

  • Nephrology
  • Radiology
  • Dermatology

Background:

  • Nephrogenic systemic fibrosis (NSF) is a debilitating condition affecting patients with chronic kidney disease (CKD) and acute renal failure.
  • NSF is characterized by progressive skin thickening and fibrosis, often symmetrically affecting the extremities, potentially leading to severe disability.
  • Systemic manifestations include cardiomyopathy, pulmonary fibrosis, and hypertension, which can be fatal.

Purpose of the Study:

  • To review the current literature on nephrogenic systemic fibrosis.
  • To highlight the association between gadolinium exposure and NSF.
  • To discuss the clinical presentation, pathophysiology, and current management strategies for NSF.

Main Methods:

  • Comprehensive literature review of studies on nephrogenic systemic fibrosis.
  • Analysis of reported cases and prevalence data.
  • Examination of pathophysiological mechanisms, including gadolinium deposition.

Main Results:

  • NSF is strongly associated with exposure to gadolinium-based contrast agents in patients with impaired renal function.
  • Prevalence of NSF can be as high as 12% in CKD stage 5 patients after a single gadolinium exposure.
  • Gadolinium deposits have been identified in affected tissues, suggesting a role in NSF pathogenesis.

Conclusions:

  • The exact pathophysiology of NSF remains unclear, but gadolinium accumulation is implicated.
  • No definitive treatment for NSF has been established, though some patients show improvement with renal function recovery, particularly after transplantation.
  • Further research is needed to elucidate NSF mechanisms and develop effective therapeutic interventions.